# Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice

> **NCT04568083** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 7035 (actual)

## Conditions studied

- Myocardial Infarction (MI)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04568083
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-25
- **Primary completion:** 2021-06-28
- **Final completion:** 2021-06-28
- **Target enrollment:** 7035 (ACTUAL)
- **Last updated:** 2022-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04568083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04568083, "Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04568083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*